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Objective: To study the correlation between expression of Wnt and NCX1 and car-
diomyocyte apoptosis in mouse with myocardial hypertrophy.
Methods: C57B/16 male mice were given the subcutaneous injection of 1 mg/kg
isoprenaline to build the myocardial hypertrophy model. After 14 d of model building,
mice were executed by cervical vertebra luxation. The ratio of heart weight/body weight
(HW/BW) and heart weight/tibia length (HW/TL) was observed and proved using HE
staining that detected the size of cardiomyocytes. 40 male C57B/16 mice were randomly
divided into the sham group (normal saline) and model group (isoprenaline), with 20 mice
in each group. The terminal deoxynucleotidyl transferase-mediated dUTP nick end la-
beling was applied to detect the cardiomyocyte apoptosis; while Western blot and
immunohistochemistry were employed to detect the expression of Wnt and NCX1.
Meanwhile, the correlation between these two proteins and cardiomyocyte apoptosis was
explored.
Results: Compared with the sham group, the ratio of HW/BW and HW/TL was
increased in the model group, as well as the bigger and hypertrophied cardiomyocytes,
decreased number and increased apoptosis of cardiomyocytes, and increased positive
expression of Wnt3a, Wnt5a and NCX1 in the cardiac muscle tissue. Besides, there was
positive correlation between the expression of Wnt and NCX1 and the cardiomyocyte
apoptosis.
Conclusion: The expression of Wnt3a, Wnt5a and NCX1 in mouse with myocardial
hypertrophy is increased and positively correlated with the cardiomyocyte apoptosis.1. Introduction
The myocardial hypertrophy is the hypertrophied and larger
heart that is caused by the increased volume of cardiomyocytes,
as the adaptive response of heart to many kinds of pathological
stimuli. Besides, the symptoms that are caused by the patho-
logical stimuli, such as the aortic stenosis and hypertension, will
be transduced through a series of cell signaling pathways, which
will ﬁnally reduce the number of cardiomyocytes, result in the
ﬁbrosis, cardiac insufﬁciency and then the heart failure,
arrhythmia and sudden death [1]. But the myocardialhypertrophy is also a reversible pathological process. When all
kinds of pathological stimuli are removed, the myocardial
hypertrophy can be improved. Therefore, the discussion on the
expression of signaling proteins in the cardiac muscle tissue
after myocardial hypertrophy will contribute to the ventricular
remodeling because of myocardial hypertrophy and even the
heart failure.
Many signaling pathways played the key role in the
myocardial hypertrophy [2]. According to plenty of previous
researches, the Wnt signaling pathway after myocardial
hypertrophy that was caused by many pathological factors was
continuously active, which would accelerate the ventricular
remodeling and the generation of arrhythmia and heart failure
[3]. After the signal is sent in the Wnt signaling pathway
through the upstream signal molecule disheveled (DVL)
protein, it can be divided into the Wnt/b-catenin classical
pathway and Wnt/b-catenin non-classical pathway. Wnt clas-
sical and non-classical signaling pathways play a vital role in then access article under the CC BY-NC-ND
Jing He et al./Asian Paciﬁc Journal of Tropical Medicine 2015; 8(11): 930–936 931heart failure because of myocardial hypertrophy, which can
become the new strategy for the treatment of myocardial hy-
pertrophy [4].
Ca2+ can regulate the contraction of cardiomyocytes, but the
myocardial hypertrophy can lead to the overload of Ca2+ in cells
that will cause the failure of contraction and ﬁnally the death of
cardiomyocytes [5]. Na+/Ca2+ exchanger (NCX) is some kind of
membrane protein that exists in cell membranes of heart, brain,
vascular smooth muscle and skeletal muscle, which can regulate
the concentration of Ca2+ in cells. In normal physiological
situation, NCX1 is the main Ca2+ pump on the membrane of
cardiomyocytes and it can transfer Ca2+ outside the
cardiomyocytes in the relaxation process. But in case of pressure
overload caused by the stimulation of many pathological factors,
NCX1 can reversely transfer Ca2+ into cells to result in the
overload of Ca2+ in cells, which will lead to the cardiomyocyte
apoptosis and heart failure [6]. According to previous researches,
it's reported that the expression of NCX1 was increased in the
myocardial hypertrophy [7–9]. It indicates that the Wnt signaling
pathway and NCX1 are similar in the biological performance
after myocardial hypertrophy, but its speciﬁc relationship has
been unknown. Therefore, in this study, the subcutaneous
injection isoprenaline (ISO) is employed to induce the
myocardial hypertrophy model of mice and thus discuss the
expression of Wnt and NCX1 after myocardial hypertrophy and
the correlation with cardiomyocyte apoptosis.
2. Materials and methods
2.1. Animals
A total of 40 C57B/16 male mice with the weight of (20 ± 2)
g were purchased from Shanghai SLAC laboratory Animal Co.,
Ltd., with the qualiﬁed certiﬁcate of SCXK (Hu)2012-0002. The
room temperature was controlled at (23 ± 2) C and mice were
given the diet and water freely.
2.2. Reagents and instruments
The rabbit-anti Wnt3a, Wnt5a and NCX1 antibodies were
purchased from Cell Signaling Technology; BCA kit and
TUNEL kit from Beyotime Biotechnology; mini vertical elec-
trophoresis tanks, mini Trans-blot electrophoresis tank and
ChemiDoc™ XRS gel imaging system from Bio-Rad.
2.3. Modeling and grouping
A total of 40 male C57B/16 mice were randomly divided into
the sham group (normal saline) and model group (ISO), with 20
mice in each group. C57B/16 male mice were given the sub-
cutaneous injection of 1 mg/kg ISO to build the myocardial
hypertrophy model that lasted for 14 d.
2.4. Ratio of heart weight/body weight (HW/BW) and
ratio of heart/tibia length (HW/TL)
After 14 d, mice were weighted and executed by cervical
vertebra luxation. The heart was taken by cutting the breast and
then it was washed with normal saline to remove the excess
connective tissues and vessels. The bibulous paper was used to
absorb the water on samples. Then the heart was weighted andput it in the refrigerator at −70 C for the measurement. After-
wards, the vernier caliper was employed to measure the left tibia
length (TL) of mice.
2.5. HE staining
After being immersed in 10% neutral formalin, samples were
embedded with parafﬁn and then cut into slices and dried. They
were deparafﬁnaged using dimethylbenzene and dehydrated
with water-free 95% and 80% ethanol. They were washed with
running water and immersed in the hematoxylin and hydro-
chloride alcohol. When being turned to be antiblue, they were
stained with eosin. Afterwards, they were washed with running
water, dehydrated with ethanol at gradient degree. They were
transparented with dimethylbenzene. After being dried, they
were mounted with the neutral resin and then observed under the
microscope.
2.6. Cardiomyocyte apoptosis detected by TUNEL
Parafﬁn sections were taken out and dehydrated. 100 mL
20 mL/mL protease K was added for the digestion. They were
incubated at the room temperature for 10 min and then washed
with PBS twice, lasting for 3 min each time. Afterwards, 50 mL
3% H2O2, was added and placed at the room temperature for
20 min. They were washed with PBS twice. TUNEL reaction
ﬂuid was added and it was reacted in the incubator in a dark
place and at 37 C for 1 h. After the reaction, 25 mL horseradish
peroxidase antibody was added. They were incubated at the
room temperature for 30 min and then washed with PBS twice.
Afterwards, they were colored using DAB, washed with running
water, re-stained with hematoxylin, anti-blued with ammonia,
dehydrated with ethanol, transparented with dimethylbenzene
and mounted with the neutral resin.
2.7. Immunohistochemistry
Parafﬁn sections were taken out and deparafﬁnaged using
dimethylbenzene. They were dehydrated with ethanol at gradient
degree and washed with running water. After being repaired
with the antigen, they were cooled at the room temperature and
washed with PBS. The primary antibodies were incubated at the
room temperature and washed with PBS; while secondary an-
tibodies were incubated at 37 C and washed with PBS. After-
wards, they were colored using DAB, re-stained, dehydrated,
transparented and mounted with the resin. Primary antibodies
were replaced by PBS as the negative control.
2.8. Western blot
Myocardial samples were collected from each group and
treated with the homogenizer. Then the appropriate RIPA lysis
buffer was added and they were shaken in the vortex every
10 min for 30 s. After 40 min, they were centrifuged at 4 C and
10000 rpm for 10 min. The supernatant was taken carefully to
obtain the total protein. BCA kit was employed to detect the
protein concentration. SDS gel electrophoresis was performed
on protein samples and then it was transferred with the wet
method. Then the ﬁlm was immersed into the primary antibody
solution for the incubation at 4 C over night. After being
washed, it was immersed into the secondary antibody solution
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Afterwards, the ﬁlm was taken out and washed, while ECL re-
agent was added on the ﬁlm for the exposure in the gel imaging
system. Statistics was performed on the gray value of each
antibody band using ‘Quantity one’ software.
2.9. Data analysis
The results were expressed as mean ± SD. The t test was
performed for the signiﬁcant difference and Pearson correlation
analysis for the correlation between two factors. P < 0.05 was
regarded to be signiﬁcant difference. All data were treated using
SPSS 17.0.
3. Results
3.1. Ratio of HW/BW and ratio of HW/TL in sham group
and model group
As shown in Table 1, compared with the sham group, the
ratios of HW/BW and HW/TL were all increased in the modelFigure 1. Size of cardiomyocytes in sham group and model group (×40).
A: Sham group; B: Model group. Compared with the sham group, **P < 0.01
Table 1
HW/BW and HW/TL in sham group and model group (mean ± SD).
Group Amount HW/BW HW/TL
Sham group 20 4.89 ± 0.69 75.42 ± 8.21
Model group 20 6.08 ± 0.78* 92.87 ± 7.65*
Note: compared with the sham group, *P < 0.05.group, namely increased by 24.33% and 23.14%, with the sta-
tistical difference (P < 0.05), which indicated the successful
building of myocardial hypertrophy model of mice.
3.2. Size of cardiomyocytes in sham group and model
group
As shown in Figure 1, compared with the sham group, car-
diomyocytes became bigger and hypertrophied in the model
group, with the statistical difference (P < 0.05), which further
indicated the successful building of myocardial hypertrophy
model of mice.
3.3. Cardiomyocyte apoptosis in sham group and model
group
As shown in Figure 2, the brown-staining of cells indicated
the apoptosis. Compared with the sham group, the number of
cardiomyocyte apoptosis was increased in the model group, with
the statistical difference (P < 0.05).
3.4. Expression of Wnt and NCX1 in cardiomyocytes in
sham group and model group
As shown in Figure 3, Wnt3a, Wnt5a and NCX1 positive
cells were stained to be brown, which indicated the increased
expression of Wnt3a, Wnt5a and NCX1. Compared with the
sham group, the positive expression of Wnt3a, Wnt5a and
NCX1 was all signiﬁcantly increased..
Figure 3. Immunohistochemistry to detect the expression of Wnt and NCX1 in cardiomyocytes in sham group and model group.
A: Wnt3a, B: Wnt5a, C: NCX1; a: sham group, b: model group.
Figure 2. Cardiomyocyte apoptosis in sham group and model group (×40).
A: sham group; B: model group. Compared with the sham group, **P < 0.01.
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Figure 4. Expression of Wnt and NCX1 in cardiomyocytes in sham group and model group. Compared with the sham group, **P < 0.01.
Table 2
Correlation between expression of Wnt and NCX1 and cardiomyocyte
apoptosis after myocardial hypertrophy of mice (mean ± SD).
Group r
Expression of Wnt3a and NCX1 0.752
Expression of Wnt5a and NCX1 0.728
Expression of Wnt and cardiomyocyte apoptosis 0.804
Expression of NCX1 and cardiomyocyte apoptosis 0.821
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sham group and model group
As shown in Figure 4, similar with the results of immuno-
histochemistry, results of Western blot showed that, compared
with the sham group, the positive expression of Wnt3a, Wnt5a
and NCX1 was all signiﬁcantly increased in the model group,
with the statistical difference (P < 0.05).
3.6. Correlation between expression of Wnt and NCX1
and cardiomyocyte apoptosis after myocardial
hypertrophy of mice
As shown in Table 2, according to Pearson correlation
analysis, after the myocardial hypertrophy, the expression of
Wnt was positively correlated with the cardiomyocyte apoptosis,
as well as the one between the expression of NCX1 and car-
diomyocyte apoptosis and the expression of Wnt and one of
NCX1, with the statistical difference (P < 0.05).4. Discussion
The myocardial hypertrophy is some kind of adaptive reac-
tion, showing the larger and heavier cardiomyocytes. The
decreased in the number of cardiomyocytes, namely the increase
in the number of cardiomyocyte apoptosis, is of compensatory
signiﬁcance in the early stage. However, the long-term
myocardial hypertrophy will lead to the arrhythmia, sudden
death and heart failure. In this study, the subcutaneous injection
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model of mice. By measuring HW/BW, HW/TL and size of
cardiomyocytes, it's found that in mice with myocardial hyper-
trophy, the ratios of HW/BW and HW/TL were all increased and
cardiomyocytes become larger and hypertrophied, which indi-
cated the successful building of model and were consistent with
ﬁndings of Mu [10] and Peng et al. [11].
Wnt was found by Nusse et al. in 1982 when inducing the
mouse mammary carcinoma using the papillomavirus. Wnt
signaling pathway is a highly conserved pathway in multicel-
lular eukaryotes, which regulates the process of many life ac-
tivities. If being exposed to the external stimulus, Wnt signaling
pathway that activates DVL protein and relies on the involve-
ment of axin protein will inhibit the phosphorylation activity of
downstream glycogen synthase kinase-3b (GSK-3b) and acti-
vate the b-catenin-induced classical signaling pathway. In this
way, b-catenin will be accumulated in the cytoplasm and
transferred to the nucleus to regulate the expression of down-
stream genes such as the cell cycle related protein (CyclinD1)
and C-myc. Malekar et al. [3] found that in the transgenic model
of rats with the overexpression of DVL-1, the expression of
CyclinD1 and C-myc was up-regulated, which resulted in the
myocardial hypertrophy. In the transgenic model of mice with
the overexpression of DVL-1 in Wnt signaling pathway, the
ratio of HW/BW was increased, being accompanied by the
larger cardiomyocytes, increased expression of atrial natriuretic
peptide, enlarged left ventricle, reduced ejection fraction, death
before the age of 6 months and disappeared effect of b-
epinephrine induced myocardial hypertrophy after the knock-
down of DVL gene [3]. According to Tateishi et al. [12], in the
myocardial hypertrophy model of mice induced by aorta
banding, LiCl could inhibit the expression of GSK-3b and
thus up-regulate the expression of b-catenin and aggravate the
myocardial hypertrophy; while in transgenic rats with the
overexpression of GSK-3b, the incidence of myocardial hyper-
trophy was inhibited. In the rat model with the knockdown of b-
catenin gene and horizontal aorta banding-induced over pressure
load, the ratio of HW/BW was decreased [13]. The transgenic
mice with the overexpression of Dapper-1 might have the
myocardial hypertrophy, increased ratio of HW/TL, cross-
sectional area of muscle cells and hypertrophied car-
diomyocytes, which was related to the up-regulated expression
of Wnt3a. Besides, after the knockdown of Dapper-1, the
expression of Wnt3a and phenylephrine-induced myocardial
hypertrophy were all decreased [14], which indicated that Wnt
classical pathway played a key role in the myocardial
hypertrophy and the expression of major proteins was
increased. According to results of this study, it also found the
increased expression of Wnt3a in the ISO-induced myocardial
hypertrophy model of mice.
Wnt signaling pathway can activate the DVL protein and also
the non-classical pathway, such as Wnt/Ca2+ signaling pathway.
In this way, it can lead to the accumulation of Ca2+ in cells and
then stimulate Ca2+ related enzymes such as CaMKⅡ and CaN.
The activated CaN can promote the introduction of downstream
cell nuclear factors into the nucleus to regulate the expression of
downstream target genes and thus be involved in the process of
development and differentiation of heart. The inhibition of
CaMKⅡ and CaN and their downstream transcription factors can
inhibit the myocardial hypertrophy and weaken the left ven-
tricular remodeling [15]. The knockdown of CaMKⅡdg in the
myocardial model of transgenic mice with the overexpressionof DVL-1 can show the normal myocardial form, without the
myocardial hypertrophy, ﬁbrosis or cardiomyocyte apoptosis.
Besides, CaMKⅡdg can be integrated with histone deacetylase 4
and myocyte enhancer factor-2 of Wnt non-classical pathway
[16], which indicated that Wnt non-classical pathway Wnt/Ca2+
also plays an important role in myocardial hypertrophy and the
expression of key proteins was increased. In this study, it also
found the increased expression of Wnt5a in ISO-induced
myocardial hypertrophy model of mice.
The excess load of heart caused by any pathological stimuli
can lead to the myocyte hypertrophy and abnormal expression of
NCX1, which will show the reverse transfer of NCX1, transfer
Na+ outside the cells and pump Ca2+ insides. In this way, it will
cause the overload of Ca2+ in cells and thus promote the inci-
dence of apoptosis [6]. Studer et al. [17] found that, compared
with the control group, levels of NCX and mRNA in patients
with end-stage dilated cardiomyopathy and ones with coronary
heart disease accompanied by heart failure were increased by
55% and 41% respectively. Meanwhile, the expression of NCX1
was increased in LPS-induced myocardial hypertrophy [6], as
well as the expression of NCX1 in myocardial hypertrophy
and heart failure [7–9] and the expression of NCX1 mRNA in
myocardial hypertrophy caused by 50% coarctation of the
abdominal aorta [18]. In cardiac myoblasts, the inhibition of
NCX1 on the cell membrane can inhibit the endoplasmic
reticulum stress and cardiomyocyte apoptosis that are caused
by the anoxia and reoxygenation injury [19]. In the situation of
intermittent hypoxia, compared with wild mice, the mice with
cardiac-speciﬁc NCX1 knockdown had the relieved left ven-
tricular dysfunction and reduced cardiomyocyte apoptosis [20].
Results showed the increased expression of NCX1 after
myocardial hypertrophy. In this study, the expression of
NCX1 was also increased in ISO-induced myocardial hyper-
trophy model of mice.
Furthermore, this study also found the positive correlation
between Wnt3a, Wnt5a, NCX1 and cardiomyocyte apoptosis in
case of hypertrophied cardiomyocytes of mice. The hypertro-
phied cardiomyocytes can activate Wnt classical and non-
classical pathways, especially the activation of Wnt/Ca2+
signaling pathway, which can promote the accumulation of Ca2+
in cells, stimulate the activity of Ca2+ related enzymes. The
activated CaN can promote the introduction of downstream cell
nuclear factors into the nucleus to regulate the expression of
related proteins and induce cardiomyocyte apoptosis. In the rat
cardiomyocytes H9c2 with anoxia and reoxygenation induced
overload of Ca2+, there was the signiﬁcant increase in the
expression of Wnt5a, as well as cardiomyocyte apoptosis [21].
NCX1 is the regulator of Ca2+ concentration. In case of
myocardial hypertrophy, it can reversely introduce Ca2+ into
cells to cause the overload of Ca2+ in cells and thus result in
the cardiomyocyte apoptosis. In mice during ischemia
reperfusion period, the increased expression of NCX1 can
reversely transfer Ca2+ to cause the overload of Ca2+ in cells
and thus result in the cardiomyocyte apoptosis [22,23]. It
indicates that Wnt is connected with NCX1 by affecting Ca2+
concentration and also play a key role in myocardial
hypertrophy, with the positive correlation between them.
In conclusion, ISO is used to build the myocardial hyper-
trophy model of mice. According to results of immunohisto-
chemistry and Western blot, compared with the sham group, the
positive expression of Wnt3a, Wnt5a and NCX1 was increased
in the cardiac muscle tissue after myocardial hypertrophy of
Jing He et al./Asian Paciﬁc Journal of Tropical Medicine 2015; 8(11): 930–936936mice. Besides, after myocardial hypertrophy, the cardiomyocyte
apoptosis also increased, showing the positive correlation among
three of them, which lay a theoretical foundation for the clinical
treatment of myocardial hypertrophy.
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